Honeywell to Buy EMS Technologies
- June 13, 2011
Honeywell is paying a 33 percent premium for a maker of systems for mobile networks and satellites. ... Read More
Honeywell is paying a 33 percent premium for a maker of systems for mobile networks and satellites. ... Read More
Applebee’s International is moving its headquarters and 390 jobs to Kansas City from Lenexa, the first big counterblow by Missouri in a cross-border business-poaching feud. Lured by a more than $12.6 ... Read More
A Houston company is in the early stages of planning one of the largest energy infrastructure projects the Midwest has seen in years – a $1.7 billion high-voltage transmission line connecting ... Read More
The banking industry appears to have regained some vigor during the past 10 years, with 21 states showing higher financial-sector employment. But the industry isn’t out of the woods 23 states ... Read More
As part of its push into health care, Nestlé said on Tuesday that it had agreed to purchase Prometheus Laboratories, an American company specializing in gastrointestinal and cancer diagnostics. ... Read More
An agriculture equipment company is relocating from Illinois to Missouri and bringing 92 jobs. Missouri Gov. Jay Nixon said Friday that Doyle Equipment Manufacturing Co. will move its headquarters and manufacturing ... Read More
General Motors supplier Flex-N-Gate will add 300 positions in Kansas City during the next five years, according to the Economic Development Corp. of Kansas City. The Kansas City Business Journal first ... Read More
Toshiba said on Thursday that it would buy Landis & Gyr for $2.3 billion, bolstering its presence in energy and infrastructure technology solutions. ... Read More
A manufacturer of biologic pharmaceuticals will locate a production facility in the St. Louis County town of Berkeley, retaining 160 workers from a plant it purchased and eventually adding another 160. ... Read More
Takeda Pharmaceutical Co., Japan's largest drugmaker, is buying privately held Swiss rival Nycomed for $13.6 billion, giving it access to a newly approved lung-disease drug, which is expected to be a major source of revenue growth. ... Read More